25 XP   0   0   10

EBOS Group Ltd
Buy, Hold or Sell?

Let's analyse EBOS Group Ltd together

PenkeI guess you are interested in EBOS Group Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of EBOS Group Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about EBOS Group Ltd

I send you an email if I find something interesting about EBOS Group Ltd.

Quick analysis of EBOS Group Ltd (30 sec.)










What can you expect buying and holding a share of EBOS Group Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$2.47
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$12.33
Expected worth in 1 year
A$14.72
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
A$6.15
Return On Investment
18.1%

For what price can you sell your share?

Current Price per Share
A$34.00
Expected price per share
A$32.20 - A$35.57
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of EBOS Group Ltd (5 min.)




Live pricePrice per Share (EOD)

A$34.00

Intrinsic Value Per Share

A$11.43 - A$19.18

Total Value Per Share

A$23.76 - A$31.51

2. Growth of EBOS Group Ltd (5 min.)




Is EBOS Group Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5b$1.4b$74.9m4.8%

How much money is EBOS Group Ltd making?

Current yearPrevious yearGrowGrow %
Making money$170.7m$139.1m$31.6m18.5%
Net Profit Margin2.1%1.9%--

How much money comes from the company's main activities?

3. Financial Health of EBOS Group Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of EBOS Group Ltd? (5 min.)

Welcome investor! EBOS Group Ltd's management wants to use your money to grow the business. In return you get a share of EBOS Group Ltd.

What can you expect buying and holding a share of EBOS Group Ltd?

First you should know what it really means to hold a share of EBOS Group Ltd. And how you can make/lose money.

Speculation

The Price per Share of EBOS Group Ltd is A$34.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of EBOS Group Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in EBOS Group Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$12.33. Based on the TTM, the Book Value Change Per Share is A$0.60 per quarter. Based on the YOY, the Book Value Change Per Share is A$4.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.94 per quarter.
Based on historical numbers we can estimate the returns while holding a share of EBOS Group Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.822.4%0.822.4%0.651.9%0.611.8%0.491.4%
Usd Book Value Change Per Share0.391.1%0.391.1%2.838.3%0.832.5%0.712.1%
Usd Dividend Per Share0.621.8%0.621.8%0.551.6%0.471.4%0.361.1%
Usd Total Gains Per Share1.013.0%1.013.0%3.389.9%1.303.8%1.073.1%
Usd Price Per Share22.16-22.16-22.79-18.54-13.72-
Price to Earnings Ratio27.09-27.09-34.83-30.68-26.99-
Price-to-Total Gains Ratio21.98-21.98-6.75-19.38-18.36-
Price to Book Ratio2.74-2.74-2.96-3.24-2.86-
Price-to-Total Gains Ratio21.98-21.98-6.75-19.38-18.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share22.3142
Number of shares44
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.620.47
Usd Book Value Change Per Share0.390.83
Usd Total Gains Per Share1.011.30
Gains per Quarter (44 shares)44.3757.14
Gains per Year (44 shares)177.48228.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11096916782147219
2217138344164293448
3326206521246440677
4435275698328587906
55433448754107331135
665241310524918801364
7761482122957310271593
8869550140665511731822
9978619158373713202051
101087688176081914672280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.02.01.089.3%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%27.01.00.096.4%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%28.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%28.00.00.0100.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of EBOS Group Ltd

About EBOS Group Ltd

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Fundamental data was last updated by Penke on 2024-02-19 15:24:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of EBOS Group Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit EBOS Group Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare EBOS Group Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 2.1% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of EBOS Group Ltd:

  • The MRQ is 2.1%. The company is making a profit. +1
  • The TTM is 2.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.1%0.0%
TTM2.1%YOY1.9%+0.2%
TTM2.1%5Y2.0%+0.0%
5Y2.0%10Y1.9%+0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%2.0%+0.1%
TTM2.1%2.1%0.0%
YOY1.9%2.1%-0.2%
5Y2.0%2.2%-0.2%
10Y1.9%2.1%-0.2%
1.1.2. Return on Assets

Shows how efficient EBOS Group Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare EBOS Group Ltd to the Medical Distribution industry mean.
  • 3.9% Return on Assets means that EBOS Group Ltd generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of EBOS Group Ltd:

  • The MRQ is 3.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.9%TTM3.9%0.0%
TTM3.9%YOY3.2%+0.7%
TTM3.9%5Y4.3%-0.3%
5Y4.3%10Y4.2%+0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9%0.9%+3.0%
TTM3.9%0.9%+3.0%
YOY3.2%0.8%+2.4%
5Y4.3%0.9%+3.4%
10Y4.2%1.0%+3.2%
1.1.3. Return on Equity

Shows how efficient EBOS Group Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare EBOS Group Ltd to the Medical Distribution industry mean.
  • 10.4% Return on Equity means EBOS Group Ltd generated $0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of EBOS Group Ltd:

  • The MRQ is 10.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.4%TTM10.4%0.0%
TTM10.4%YOY8.9%+1.5%
TTM10.4%5Y11.6%-1.2%
5Y11.6%10Y11.4%+0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ10.4%2.5%+7.9%
TTM10.4%2.5%+7.9%
YOY8.9%2.2%+6.7%
5Y11.6%2.4%+9.2%
10Y11.4%2.4%+9.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of EBOS Group Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient EBOS Group Ltd is operating .

  • Measures how much profit EBOS Group Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare EBOS Group Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 3.7% means the company generated $0.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of EBOS Group Ltd:

  • The MRQ is 3.7%. The company is operating less efficient.
  • The TTM is 3.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.7%TTM3.7%0.0%
TTM3.7%YOY3.1%+0.6%
TTM3.7%5Y3.2%+0.5%
5Y3.2%10Y3.0%+0.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%3.1%+0.6%
TTM3.7%2.6%+1.1%
YOY3.1%3.5%-0.4%
5Y3.2%3.2%+0.0%
10Y3.0%2.0%+1.0%
1.2.2. Operating Ratio

Measures how efficient EBOS Group Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are $0.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of EBOS Group Ltd:

  • The MRQ is 0.963. The company is less efficient in keeping operating costs low.
  • The TTM is 0.963. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.963TTM0.9630.000
TTM0.963YOY0.967-0.004
TTM0.9635Y0.967-0.004
5Y0.96710Y0.969-0.002
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9631.456-0.493
TTM0.9631.576-0.613
YOY0.9671.506-0.539
5Y0.9671.408-0.441
10Y0.9691.233-0.264
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of EBOS Group Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if EBOS Group Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.13 means the company has $1.13 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of EBOS Group Ltd:

  • The MRQ is 1.131. The company is just able to pay all its short-term debts.
  • The TTM is 1.131. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.131TTM1.1310.000
TTM1.131YOY1.220-0.089
TTM1.1315Y1.162-0.030
5Y1.16210Y1.178-0.016
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1311.366-0.235
TTM1.1311.418-0.287
YOY1.2201.403-0.183
5Y1.1621.408-0.246
10Y1.1781.298-0.120
1.3.2. Quick Ratio

Measures if EBOS Group Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare EBOS Group Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.65 means the company can pay off $0.65 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of EBOS Group Ltd:

  • The MRQ is 0.648. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.648. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.648TTM0.6480.000
TTM0.648YOY0.759-0.111
TTM0.6485Y0.706-0.058
5Y0.70610Y0.746-0.040
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6480.731-0.083
TTM0.6480.743-0.095
YOY0.7590.828-0.069
5Y0.7060.785-0.079
10Y0.7460.850-0.104
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of EBOS Group Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of EBOS Group Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare EBOS Group Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.64 means that EBOS Group Ltd assets are financed with 64.2% credit (debt) and the remaining percentage (100% - 64.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of EBOS Group Ltd:

  • The MRQ is 0.642. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.642. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.642TTM0.6420.000
TTM0.642YOY0.657-0.014
TTM0.6425Y0.641+0.001
5Y0.64110Y0.630+0.011
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6420.610+0.032
TTM0.6420.606+0.036
YOY0.6570.608+0.049
5Y0.6410.610+0.031
10Y0.6300.593+0.037
1.4.2. Debt to Equity Ratio

Measures if EBOS Group Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare EBOS Group Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 169.8% means that company has $1.70 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of EBOS Group Ltd:

  • The MRQ is 1.698. The company is just able to pay all its debts with equity.
  • The TTM is 1.698. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.698TTM1.6980.000
TTM1.698YOY1.816-0.118
TTM1.6985Y1.750-0.052
5Y1.75010Y1.700+0.050
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6981.698+0.000
TTM1.6981.644+0.054
YOY1.8161.752+0.064
5Y1.7501.695+0.055
10Y1.7001.738-0.038
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of EBOS Group Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings EBOS Group Ltd generates.

  • Above 15 is considered overpriced but always compare EBOS Group Ltd to the Medical Distribution industry mean.
  • A PE ratio of 27.09 means the investor is paying $27.09 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of EBOS Group Ltd:

  • The EOD is 27.275. Based on the earnings, the company is overpriced. -1
  • The MRQ is 27.090. Based on the earnings, the company is overpriced. -1
  • The TTM is 27.090. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD27.275MRQ27.090+0.185
MRQ27.090TTM27.0900.000
TTM27.090YOY34.831-7.741
TTM27.0905Y30.681-3.591
5Y30.68110Y26.991+3.690
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD27.27514.032+13.243
MRQ27.09017.338+9.752
TTM27.09018.566+8.524
YOY34.83118.000+16.831
5Y30.68115.584+15.097
10Y26.99115.886+11.105
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of EBOS Group Ltd:

  • The EOD is 21.755. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.608. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 21.608. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD21.755MRQ21.608+0.147
MRQ21.608TTM21.6080.000
TTM21.608YOY40.190-18.582
TTM21.6085Y31.849-10.241
5Y31.84910Y27.055+4.794
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD21.7556.318+15.437
MRQ21.6087.054+14.554
TTM21.6085.381+16.227
YOY40.1905.232+34.958
5Y31.8492.484+29.365
10Y27.0552.519+24.536
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of EBOS Group Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 2.74 means the investor is paying $2.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of EBOS Group Ltd:

  • The EOD is 2.757. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.738. Based on the equity, the company is underpriced. +1
  • The TTM is 2.738. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.757MRQ2.738+0.019
MRQ2.738TTM2.7380.000
TTM2.738YOY2.958-0.220
TTM2.7385Y3.240-0.501
5Y3.24010Y2.860+0.380
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD2.7571.102+1.655
MRQ2.7381.296+1.442
TTM2.7381.224+1.514
YOY2.9581.307+1.651
5Y3.2401.360+1.880
10Y2.8602.166+0.694
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of EBOS Group Ltd.

3.1. Funds holding EBOS Group Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-02-28Fidelity Overseas Fund (US)1.37-2243701--
2021-02-28Fidelity International Discovery Fund0.93-1521700--
2020-10-31Vanguard International Stock Index-Total Intl Stock Indx0.87-1426138--
2021-01-31Fidelity International Small Cap Fund0.46-747510--
2020-12-31Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund0.36000002-592143--
2021-01-31Fidelity Series Intrinsic Opportunities Fund0.3-495517--
2021-02-28Variable Insurance Products Fund-Overseas Portfolio0.29-469936--
2021-02-28Fidelity Pacific Basin Fund0.25-416179--
2021-01-31Fidelity Series International Small Cap Fund0.21-336913--
2021-01-31DFA International Core Equity Portfolio0.2-322374--
Total 5.240000020857211100.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of EBOS Group Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5960.5960%4.306-86%1.270-53%1.083-45%
Book Value Per Share--12.33312.3330%11.737+5%8.956+38%7.177+72%
Current Ratio--1.1311.1310%1.220-7%1.162-3%1.178-4%
Debt To Asset Ratio--0.6420.6420%0.657-2%0.641+0%0.630+2%
Debt To Equity Ratio--1.6981.6980%1.816-6%1.750-3%1.7000%
Dividend Per Share--0.9410.9410%0.841+12%0.709+33%0.546+72%
Eps--1.2471.2470%0.997+25%0.926+35%0.749+66%
Free Cash Flow Per Share--1.5631.5630%0.864+81%1.010+55%0.826+89%
Free Cash Flow To Equity Per Share---1.367-1.3670%9.055-115%1.726-179%1.224-212%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--19.178--------
Intrinsic Value_10Y_min--11.432--------
Intrinsic Value_1Y_max--1.350--------
Intrinsic Value_1Y_min--0.916--------
Intrinsic Value_3Y_max--4.492--------
Intrinsic Value_3Y_min--2.967--------
Intrinsic Value_5Y_max--8.159--------
Intrinsic Value_5Y_min--5.239--------
Market Cap6521608000.000+1%6477491240.0006477491240.0000%6659712640.000-3%5419456248.000+20%4009062612.000+62%
Net Profit Margin--0.0210.0210%0.019+10%0.020+1%0.019+9%
Operating Margin--0.0370.0370%0.031+21%0.032+15%0.030+22%
Operating Ratio--0.9630.9630%0.9670%0.9670%0.969-1%
Pb Ratio2.757+1%2.7382.7380%2.958-7%3.240-15%2.860-4%
Pe Ratio27.275+1%27.09027.0900%34.831-22%30.681-12%26.991+0%
Price Per Share34.000+1%33.77033.7700%34.720-3%28.254+20%20.901+62%
Price To Free Cash Flow Ratio21.755+1%21.60821.6080%40.190-46%31.849-32%27.055-20%
Price To Total Gains Ratio22.128+1%21.97821.9780%6.746+226%19.384+13%18.359+20%
Quick Ratio--0.6480.6480%0.759-15%0.706-8%0.746-13%
Return On Assets--0.0390.0390%0.032+22%0.043-8%0.042-7%
Return On Equity--0.1040.1040%0.089+16%0.116-11%0.114-8%
Total Gains Per Share--1.5371.5370%5.147-70%1.979-22%1.629-6%
Usd Book Value--1552493992.8611552493992.8610%1477510672.560+5%1127493247.042+38%903519726.186+72%
Usd Book Value Change Per Share--0.3910.3910%2.826-86%0.833-53%0.711-45%
Usd Book Value Per Share--8.0948.0940%7.703+5%5.878+38%4.710+72%
Usd Dividend Per Share--0.6180.6180%0.552+12%0.465+33%0.358+72%
Usd Eps--0.8180.8180%0.654+25%0.608+35%0.492+66%
Usd Free Cash Flow--196741469.136196741469.1360%108753615.730+81%127181430.947+55%103990254.909+89%
Usd Free Cash Flow Per Share--1.0261.0260%0.567+81%0.663+55%0.542+89%
Usd Free Cash Flow To Equity Per Share---0.897-0.8970%5.943-115%1.133-179%0.803-212%
Usd Market Cap4280131330.400+1%4251177500.8124251177500.8120%4370769405.632-3%3556789135.562+20%2631147792.256+62%
Usd Price Per Share22.314+1%22.16322.1630%22.787-3%18.543+20%13.717+62%
Usd Profit--170776630.861170776630.8610%139132353.426+23%129737081.972+32%102488931.711+67%
Usd Revenue--8248164221.2918248164221.2910%7371304945.365+12%6409041109.478+29%5320351958.549+55%
Usd Total Gains Per Share--1.0081.0080%3.378-70%1.299-22%1.069-6%
 EOD+4 -4MRQTTM+0 -0YOY+24 -115Y+23 -1210Y+22 -13

4.2. Fundamental Score

Let's check the fundamental score of EBOS Group Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.275
Price to Book Ratio (EOD)Between0-12.757
Net Profit Margin (MRQ)Greater than00.021
Operating Margin (MRQ)Greater than00.037
Quick Ratio (MRQ)Greater than10.648
Current Ratio (MRQ)Greater than11.131
Debt to Asset Ratio (MRQ)Less than10.642
Debt to Equity Ratio (MRQ)Less than11.698
Return on Equity (MRQ)Greater than0.150.104
Return on Assets (MRQ)Greater than0.050.039
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of EBOS Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.459
Ma 20Greater thanMa 5034.259
Ma 50Greater thanMa 10033.728
Ma 100Greater thanMa 20033.541
OpenGreater thanClose34.330
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in NZD. All numbers in thousands.

Summary
Total Assets7,005,151
Total Liabilities4,498,501
Total Stockholder Equity2,649,246
 As reported
Total Liabilities 4,498,501
Total Stockholder Equity+ 2,649,246
Total Assets = 7,005,151

Assets

Total Assets7,005,151
Total Current Assets3,272,257
Long-term Assets3,732,894
Total Current Assets
Cash And Cash Equivalents 230,587
Short-term Investments 14,734
Net Receivables 1,629,694
Inventory 1,343,168
Other Current Assets 68,808
Total Current Assets  (as reported)3,272,257
Total Current Assets  (calculated)3,286,991
+/- 14,734
Long-term Assets
Property Plant Equipment 718,985
Goodwill 2,150,798
Long Term Investments 58,385
Intangible Assets 560,740
Other Assets 208,597
Long-term Assets  (as reported)3,732,894
Long-term Assets  (calculated)3,697,504
+/- 35,389

Liabilities & Shareholders' Equity

Total Current Liabilities2,892,647
Long-term Liabilities1,605,855
Total Stockholder Equity2,649,246
Total Current Liabilities
Short-term Debt 100,409
Short Long Term Debt 45,842
Accounts payable 2,270,424
Other Current Liabilities 620,429
Total Current Liabilities  (as reported)2,892,647
Total Current Liabilities  (calculated)3,037,104
+/- 144,457
Long-term Liabilities
Long term Debt 1,018,991
Capital Lease Obligations 331,340
Other Liabilities 284,943
Long-term Liabilities  (as reported)1,605,855
Long-term Liabilities  (calculated)1,635,274
+/- 29,419
Total Stockholder Equity
Common Stock2,056,658
Retained Earnings 608,802
Accumulated Other Comprehensive Income -16,214
Total Stockholder Equity (as reported)2,649,246
Total Stockholder Equity (calculated)2,649,246
+/- 0
Other
Capital Stock2,056,658
Cash and Short Term Investments 230,587
Common Stock Shares Outstanding 190,602
Current Deferred Revenue-98,615
Liabilities and Stockholders Equity 7,005,151
Net Debt 1,165,586
Net Invested Capital 3,714,079
Net Tangible Assets -57,240
Net Working Capital 379,610
Property Plant and Equipment Gross 1,020,500
Short Long Term Debt Total 1,396,173



Balance Sheet

Currency in NZD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-30
> Total Assets 
12,602
13,864
26,055
29,513
35,180
0
60,354
90,388
92,620
92,539
119,114
134,735
137,226
486,194
499,833
518,343
538,319
657,999
2,531,739
2,309,293
2,550,058
3,192,896
3,205,574
3,263,298
3,350,295
4,010,264
4,243,857
6,945,942
7,005,151
7,005,1516,945,9424,243,8574,010,2643,350,2953,263,2983,205,5743,192,8962,550,0582,309,2932,531,739657,999538,319518,343499,833486,194137,226134,735119,11492,53992,62090,38860,354035,18029,51326,05513,86412,602
   > Total Current Assets 
11,293
12,677
19,974
22,655
29,295
0
42,107
67,517
62,165
60,454
77,239
86,253
90,025
299,721
314,582
336,392
378,000
396,739
1,505,804
1,287,871
1,441,839
2,027,468
1,784,052
1,756,235
1,881,387
2,161,869
2,282,847
3,397,999
3,272,257
3,272,2573,397,9992,282,8472,161,8691,881,3871,756,2351,784,0522,027,4681,441,8391,287,8711,505,804396,739378,000336,392314,582299,72190,02586,25377,23960,45462,16567,51742,107029,29522,65519,97412,67711,293
       Cash And Cash Equivalents 
625
3,183
0
117
2,398
0
311
1,120
566
1,674
2,755
1,938
1,772
16,136
33,609
56,484
99,678
52,646
198,014
88,698
109,521
120,251
162,181
163,256
174,325
261,991
181,533
573,585
230,587
230,587573,585181,533261,991174,325163,256162,181120,251109,52188,698198,01452,64699,67856,48433,60916,1361,7721,9382,7551,6745661,12031102,39811703,183625
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
1,049
12
130
0
105
0
109
3,546
1,442
2,184
2,852
19
0
0
-95
-93
17,016
14,734
14,73417,016-93-9500192,8522,1841,4423,54610901050130121,04900000000000
       Net Receivables 
4,248
4,483
9,047
8,351
11,193
0
17,338
30,900
29,728
29,178
38,718
38,202
41,230
150,426
150,720
148,178
152,797
175,712
736,429
699,276
803,839
1,320,387
1,041,849
998,760
939,314
1,094,495
1,242,612
1,524,261
1,629,694
1,629,6941,524,2611,242,6121,094,495939,314998,7601,041,8491,320,387803,839699,276736,429175,712152,797148,178150,720150,42641,23038,20238,71829,17829,72830,90017,338011,1938,3519,0474,4834,248
       Inventory 
6,419
5,011
10,927
14,187
15,703
0
24,459
34,972
31,871
29,602
35,476
43,470
45,211
126,704
127,380
128,484
121,807
162,997
558,350
491,624
518,272
575,661
572,001
582,877
756,975
789,574
843,194
1,241,882
1,343,168
1,343,1681,241,882843,194789,574756,975582,877572,001575,661518,272491,624558,350162,997121,807128,484127,380126,70445,21143,47035,47629,60231,87134,97224,459015,70314,18710,9275,0116,419
   > Long-term Assets 
1,309
1,187
6,081
6,858
5,885
0
18,247
22,872
30,456
32,085
41,875
48,482
47,201
186,473
185,251
181,951
160,319
261,260
1,025,935
1,021,422
1,108,219
1,165,428
1,421,522
1,507,063
1,468,908
1,848,396
1,961,010
3,547,943
3,732,894
3,732,8943,547,9431,961,0101,848,3961,468,9081,507,0631,421,5221,165,4281,108,2191,021,4221,025,935261,260160,319181,951185,251186,47347,20148,48241,87532,08530,45622,87218,24705,8856,8586,0811,1871,309
       Property Plant Equipment 
1,269
1,137
2,341
3,192
2,308
0
3,504
14,111
13,832
13,137
10,992
11,054
10,765
23,019
19,444
17,815
16,974
23,498
95,918
105,726
111,599
104,467
138,799
185,726
189,340
430,716
499,557
639,735
718,985
718,985639,735499,557430,716189,340185,726138,799104,467111,599105,72695,91823,49816,97417,81519,44423,01910,76511,05410,99213,13713,83214,1113,50402,3083,1922,3411,1371,269
       Goodwill 
0
0
806
716
627
0
3,194
4,966
4,298
6,174
19,168
27,869
27,387
133,062
133,915
133,741
114,132
180,553
722,158
720,875
764,618
829,163
1,000,050
1,021,170
990,851
1,037,807
1,073,750
2,372,809
2,150,798
2,150,7982,372,8091,073,7501,037,807990,8511,021,1701,000,050829,163764,618720,875722,158180,553114,132133,741133,915133,06227,38727,86919,1686,1744,2984,9663,194062771680600
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,100
34,911
38,033
37,377
50,412
53,157
61,283
60,767
65,858
58,385
58,38565,85860,76761,28353,15750,41237,37738,03334,91124,1000000000000000000000
       Intangible Assets 
0
0
2,685
2,685
2,685
0
2,685
2,685
7,646
7,646
7,646
6,463
6,316
25,109
24,439
23,919
23,828
31,160
154,469
134,078
148,368
146,488
196,024
196,725
178,019
177,986
174,539
267,563
560,740
560,740267,563174,539177,986178,019196,725196,024146,488148,368134,078154,46931,16023,82823,91924,43925,1096,3166,4637,6467,6467,6462,6852,68502,6852,6852,68500
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,643
46,955
43,481
49,272
48,682
54,998
0
141,836
182,165
208,597
208,597182,165141,836054,99848,68249,27243,48146,95536,6430000000000000000000
> Total Liabilities 
6,980
6,192
16,594
18,912
22,776
0
21,492
44,401
48,058
44,203
64,684
78,972
43,076
338,890
337,794
335,553
339,523
449,398
2,226,862
1,330,254
1,499,030
2,105,619
2,053,176
2,047,080
2,053,727
2,607,210
2,733,486
4,560,360
4,498,501
4,498,5014,560,3602,733,4862,607,2102,053,7272,047,0802,053,1762,105,6191,499,0301,330,2542,226,862449,398339,523335,553337,794338,89043,07678,97264,68444,20348,05844,40121,492022,77618,91216,5946,1926,980
   > Total Current Liabilities 
6,980
6,192
16,007
17,300
21,901
0
19,058
35,261
38,715
34,393
37,805
62,029
34,971
323,636
254,256
261,698
268,355
302,475
2,009,484
1,021,333
1,162,265
1,781,183
1,541,861
1,493,913
1,591,370
1,891,886
2,017,813
2,784,821
2,892,647
2,892,6472,784,8212,017,8131,891,8861,591,3701,493,9131,541,8611,781,1831,162,2651,021,3332,009,484302,475268,355261,698254,256323,63634,97162,02937,80534,39338,71535,26119,058021,90117,30016,0076,1926,980
       Short-term Debt 
0
0
0
0
0
0
0
0
10,679
10,257
9,091
25,783
1,810
83,473
2,804
176
5
10,997
216,864
153,489
153,398
107,119
155,929
160,318
176,090
300,511
164,541
414,840
100,409
100,409414,840164,541300,511176,090160,318155,929107,119153,398153,489216,86410,99751762,80483,4731,81025,7839,09110,25710,67900000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
407,446
159,292
106,976
155,857
160,293
176,090
264,284
125,325
367,576
45,842
45,842367,576125,325264,284176,090160,293155,857106,976159,292407,4460000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
775,774
865,482
1,539,855
1,229,981
1,174,453
1,245,657
1,388,046
1,578,599
1,959,831
2,270,424
2,270,4241,959,8311,578,5991,388,0461,245,6571,174,4531,229,9811,539,855865,482775,7740000000000000000000
       Other Current Liabilities 
2,332
2,125
5,762
6,192
13,118
0
6,721
35,261
28,036
1,986
2,287
12,301
8,204
19,690
23,281
26,363
23,729
33,269
1,011,464
92,070
143,385
134,209
155,951
159,142
169,622
503,063
438,540
827,050
620,429
620,429827,050438,540503,063169,622159,142155,951134,209143,38592,0701,011,46433,26923,72926,36323,28119,6908,20412,3012,2871,98628,03635,2616,721013,1186,1925,7622,1252,332
   > Long-term Liabilities 
0
0
587
1,612
874
0
2,433
9,140
9,343
9,810
26,878
16,943
8,105
15,254
83,538
73,855
71,168
146,923
217,378
308,921
336,765
324,436
511,315
553,167
462,357
715,324
715,672
1,775,539
1,605,855
1,605,8551,775,539715,672715,324462,357553,167511,315324,436336,765308,921217,378146,92371,16873,85583,53815,2548,10516,94326,8789,8109,3439,1402,43308741,61258700
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
263,137
239,777
405,548
435,121
364,038
528,216
527,186
0
0
00527,186528,216364,038435,121405,548239,777263,13700000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,415
63,722
63,728
70,365
72,686
77,883
140,111
138,890
327,897
284,943
284,943327,897138,890140,11177,88372,68670,36563,72863,72257,4150000000000000000000
> Total Stockholder Equity
5,622
7,672
9,461
10,601
12,404
0
38,862
45,987
43,286
48,177
50,426
55,763
94,150
147,304
162,039
182,790
198,796
208,601
304,877
979,039
1,051,028
1,087,277
1,132,070
1,192,959
1,299,781
1,407,414
1,516,089
2,511,156
2,649,246
2,649,2462,511,1561,516,0891,407,4141,299,7811,192,9591,132,0701,087,2771,051,028979,039304,877208,601198,796182,790162,039147,30494,15055,76350,42648,17743,28645,98738,862012,40410,6019,4617,6725,622
   Common Stock
1,109
1,111
3,199
3,386
3,398
35,475
25,424
25,818
26,255
26,702
26,758
26,837
63,150
105,752
105,861
106,000
107,970
107,970
201,288
861,549
880,628
888,513
888,513
888,513
974,902
1,029,098
1,067,601
2,007,498
2,056,658
2,056,6582,007,4981,067,6011,029,098974,902888,513888,513888,513880,628861,549201,288107,970107,970106,000105,861105,75263,15026,83726,75826,70226,25525,81825,42435,4753,3983,3863,1991,1111,109
   Retained Earnings 
3,340
4,859
5,770
6,444
7,872
0
12,267
14,528
16,845
20,179
23,678
28,258
31,485
39,645
56,555
76,738
88,824
100,359
107,268
147,085
189,595
239,578
277,912
326,800
338,601
398,172
465,728
534,057
608,802
608,802534,057465,728398,172338,601326,800277,912239,578189,595147,085107,268100,35988,82476,73856,55539,64531,48528,25823,67820,17916,84514,52812,26707,8726,4445,7704,8593,340
   Accumulated Other Comprehensive Income 
-1,018
-783
-1,736
-1,560
-1,753
0
0
-5,814
186
1,296
-10
668
-485
1,907
-377
52
2,002
272
-3,679
-29,595
-19,195
-40,814
-34,355
-22,354
-13,721
-19,856
-17,240
-30,398
-16,214
-16,214-30,398-17,240-19,856-13,721-22,354-34,355-40,814-19,195-29,595-3,6792722,00252-3771,907-485668-101,296186-5,81400-1,753-1,560-1,736-783-1,018
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
2,191
2,485
2,227
2,330
2,887
0
1,171
11,454
0
0
0
0
0
0
0
0
0
0
0
-29,595
-18,499
-37,537
-34,355
-20,643
-13,115
-1,425,067
-1,530,975
-2,534,048
-2,657,776
-2,657,776-2,534,048-1,530,975-1,425,067-13,115-20,643-34,355-37,537-18,499-29,5950000000000011,4541,17102,8872,3302,2272,4852,191



Balance Sheet

Currency in NZD. All numbers in thousands.




Cash Flow

Currency in NZD. All numbers in thousands.